GNH USA

Europe — EMA

Olpam (Carbidopa, Levodopa)

Carbidopa, the active ingredient in Olpam, is a dopamine precursor presented as a tablet for oral use. It is used in combination with levodopa to manage symptoms of Parkinson's disease in adults.

Request sourcing

1
Pack/s

What is Carbidopa, Levodopa?

Carbidopa, the active ingredient in Olpam, is a dopamine precursor presented as a tablet for oral use. It is used in combination with levodopa to manage symptoms of Parkinson's disease in adults. GNH USA supplies Olpam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olpam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Carbidopa, Levodopa used for?

Olpam combines the car‑dopa‑levodopa duo to address the dopaminergic deficiency in Parkinson’s disease. It offers the following clinical benefits: - Parkinson's disease: Improves motor symptoms such as tremor, rigidity and brady‑brady by restoring dopamine levels. - Restless of    ...

What are the side effects of Carbidopa, Levodopa?

Common ...

What precautions apply to Carbidopa, Levodopa?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Carbidopa, Levodopa
Route
Oral Use
Manufacturer
Medochemie Ltd.
Origin
EU

Related products